NEUTROPEG pegfilgrastim 6 mg/0.6 mL solution for injection pre-filled syringe

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

Pegfilgrastim, Quantity: 6 mg

Disponible desde:

Accord Healthcare Pty Ltd

formulario farmacéutico:

Injection, solution

Composición:

Excipient Ingredients: glacial acetic acid; polysorbate 20; sodium hydroxide; sorbitol; water for injections

Vía de administración:

Subcutaneous

Unidades en paquete:

1 prefilled syringe

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

For the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infection, as manifested by febrile neutropenia.

Resumen del producto:

Visual Identification: clear and colourless liquid; Container Type: Syringe; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estado de Autorización:

Registered

Fecha de autorización:

2019-08-19